|
|
|
| Characteristics of ultrasound and BRAFV600E gene mutation in papillary thyroid micropapillary carcinoma with cervical lymph node metastasis |
| ZHONG Lichang1 GU Liping1 MA Fang1 XIONG Miao2 |
1.Department of Ultrasound, East Branch of Shanghai Sixth People’s Hospital, Shanghai Jiaotong University, Shanghai 201306, China;
2.Department of Obstetrics and Gynecology, East Branch of Shanghai Sixth People’s Hospital, Shanghai Jiaotong University, Shanghai 201306, China |
|
|
|
Abstract Objective To analyzed ultrasonographic images of papillary thyroid micropapillary carcinoma (PTMC) with cervical lymph node metastasis and characteristics of BRAFV600E gene mutation. Methods A total of 127 cases of PTMC admitted to the East Branch of Shanghai Sixth People’s Hospital, Affiliated to Shanghai Jiaotong University from June 2013 to June 2017 were selected as study subjects. According to the presence or absence of cervical lymph node metastasis, they were divided into PTMC cervical lymph node metastasis group (61 cases) and PTMC non-cervical lymph node metastasis group (66 cases). The ultrasound characteristics and BRAFV600E gene mutation were compared between the two groups. Results There were significant differences in nodule maximum diameter, whether nodule contact with thyroid capsule, nodule shape, calcification, aspect ratio between PTMC cervical lymph node metastasis group and PTMC non-cervical lymph node metastasis group (all P < 0.05). The positive rate of BRAFV600E gene mutation in the PTMC cervical lymph node metastasis group was higher than that in the PTMC non-cervical lymph node metastasis group (P < 0.05). Conclusion In PTMC patients, cervical lymph node metastasis is likely to occur if the nodules show ultrasonic signs such as nodule maximum diameter > 5 mm, nodule contact with thyroid capsule, irregular shape of nodules, aspect ratio≥1, nodules with microcalcification, and BRAFV600E gene mutation positive.
|
|
|
|
|
|
[1] 钟李长，卢峰，郭乐杭，等.超声造影在甲状腺结节良恶性鉴别诊断中的应用价值[J].同济大学学报：医学版，2015，36（2）：109-111.
[2] Li F，Chen G，Sheng C，et al. BRAFV600E mutation in papillary thyroid microcarcinoma：a meta-analysis [J]. Endocr Relat Cancer，2015，22（2）：159-168.
[3] 薛金才，刘勤江，田尤新，等.BRAFV600E及TERT启动子突变在甲状腺微小乳头状癌风险评估中的价值[J].中国癌症杂志，2018，28（5）：335-341.
[4] 张伟娜，阮莹，许教远，等.超声引导下细针穿刺细胞学检查联合BRAFV600E基因突变检测在甲状腺微小结节良恶性鉴别诊断中的价值[J].新医学，2019，50（7）：527-531.
[5] 黄丽燕，何以敉，薛恩生，等.超声对甲状腺癌颈部转移性淋巴结区域及特点的评价[J].中华超声影像学杂志，2014，23（9）：769-772.
[6] 张晓晓，詹维伟，周伟，等.术前超声检查评估甲状腺微小乳头状癌颈部淋巴结转移的临床价值[J].中华医学超声杂志：电子版，2014，11（11）：919-924.
[7] 赵巧玲，李芬，张华，等.比较超声弹性成像与CDFI鉴别诊断良恶性乳腺病变[J].中国医学影像技术，2013，29（1）：75-78.
[8] 孙嘉伟，许晓君，蔡秋茂，等.中国甲状腺癌发病趋势分析[J].中国肿瘤，2013，22（9）：690-693.
[9] 莫伶丽.多模态超声成像技术在甲状腺结节诊疗中的应用研究进展[J].吉林医学，2016，37（12）：3025-3027.
[10] Haugen BR，Alexander EK，Bible KC，et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer：The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J]. Thyroid，2016，26（1）：1-133.
[11] Kim KE，Kim EK，Yoon JH，et al. Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features [J]. World J Surg，2013，37（2）：385-391.
[12] Mulla M，Schulte KM. Central cervical lymph node metastases in papillary thyroid cancer：a systematic review of imaging-guided and prophylactic removal of the central compartment [J]. Clin Endocrinol（Oxf），2012，76（1）：131-136.
[13] Chen Q，Zou XH，Wei T，et al. Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma：a retrospective study [J]. Gland Surgery，2015，4（4）：288-294.
[14] Zhao Q，Ming J，Liu C，et al. Multifocality and Total Tumor Diameter Predict Central Neck Lymph Node Metastases in Papillary Thyroid Microcarcinoma [J]. Ann Surg Oncol，2013，20（3）：746-752.
[15] Siddiqui S，White MG，Antic T，et al. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma [J]. Thyroid，2016，26（6）：807-815.
[16] 谭卓，聂喜林，郑传铭，等.甲状腺微小乳头状癌侧颈部淋巴结转移相关危险因素分析[J].浙江医学，2016，38（11）：787-790.
[17] Yang Y，Chen C，Chen Z，et al. Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma [J]. Clin Endocrinol（Oxf），2014，81（2）：282-288.
[18] 张剑，王跃涛，徐斌，等.甲状腺微小乳头状癌原发灶超声特征与颈部淋巴结转移的关系[J].中国医学影像学杂志，2016，24（8）：573-577，579.
[19] 王文涵，詹维伟，徐上妍，等.甲状腺微小乳头状癌的超声特征与颈部淋巴结转移的关系[J].中华超声影像学杂志，2014，23（3）：231-234.
[20] 董永玲，邢萍，陈琪，等.甲状腺乳头状癌伴颈部淋巴结转移相关超声征象分析[J].中华医学超声杂志：电子版，2014，11（2）：172-176.
[21] Lee YK，Park KH，Park SH，et al. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAFV600E mutation [J]. Head Neck，2018，40（10）：2271-2279.
[22] Czarniecka A，Kowal M，Rusinek D，et al. The Risk of Relapse in Papillary Thyroid Cancer（PTC）in the Context of BRAFV600E Mutation Status and Other Prognostic Factors [J]. PLoS One，2015，10（7）：e0132821.
[23] So YK，Son YI，Hong SD，et al. Subclinical lymph node metastasis in papillary thyroid microcarcinoma：a study of 551 resections [J]. Surgery，2010，148（3）：526-531.
[24] Zheng X，Wei S，Han Y，et al. Papillary Microcarcinoma of the Thyroid：Clinical Characteristics and BRAFV600E Mutational Status of 977 Cases [J]. Ann Surg Oncol，2013， 20（7）：2266-2273. |
|
|
|
